JGGDR
OCUL icon

JGP Global Gestao de Recursos’s Ocular Therapeutix OCUL Stock Holding History

JGP Global Gestao de Recursos’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,880
Closed -$55K – 74
2019
Q1 		$55K Buy
13,880
+1,312
+10% +$5.28K 0.02% 64
2018
Q4 		$50K Buy
+12,568
New +$69.3K 0.06% 54

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JGP Global Gestao de Recursos's OCUL Position: Q2 2019 in Review

JGP Global Gestao de Recursos sold out of Ocular Therapeutix (OCUL) in Q2 2019, closing a stake of 13,880 shares — an estimated $55K sold.

JGP Global Gestao de Recursos first reported a position in OCUL in Q4 2018 and held it in 2 quarters. The position peaked at $55K in Q1 2019. 68 funds tracked by Wall St. Rank hold OCUL as of Q2 2019.

  • JGP Global Gestao de Recursos reported no remaining Ocular Therapeutix position as of Q2 2019 after selling out during the quarter.
  • JGP Global Gestao de Recursos sold 13,880 Ocular Therapeutix shares in Q2 2019, an estimated $55K.
  • JGP Global Gestao de Recursos first reported a position in Ocular Therapeutix in Q4 2018 and held it in 2 quarters.
  • JGP Global Gestao de Recursos's Ocular Therapeutix position peaked at $55K in Q1 2019.
  • 68 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2019.

Based on JGP Global Gestao de Recursos's 13F filing for Q2 2019, filed 19 Jul 2019.